PRCT - PROCEPT BioRobotics Corp


54.16
1.670   3.083%

Share volume: 998,223
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%

$52.49
1.67
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
25%
Profitability 0%
Dept financing 15%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
3.04%
1 Month
-7.04%
3 Months
-25.76%
6 Months
-43.99%
1 Year
4.05%
2 Year
73.09%
Key data
Stock price
$54.16
P/E Ratio 
0.00
DAY RANGE
$52.66 - $54.59
EPS 
-$0.34
52 WEEK RANGE
$47.04 - $103.81
52 WEEK CHANGE
$2.23
MARKET CAP 
4.202 B
YIELD 
N/A
SHARES OUTSTANDING 
51.932 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
0.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,769,514
AVERAGE 30 VOLUME 
$1,271,889
Company detail
CEO: Reza Zadno
Region: US
Website: procept-biorobotics.com
Employees: 430
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery.

Recent news
loading